Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

NCT06966232 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancers

Interventions

DRUG: Entecavir

Sponsor

Sun Yat-sen University